Hospital
Dupont Hospital LLC
Dupont Hospital LLC was paid $3.81M by Medicaid between Jan 2018 and Nov 2024, across 62 billing codes. Its largest line is 99283, emergency room visit (moderate) — 41% of everything it billed.
33Billing provider infoDUPONT HOSPITAL LLC
FORT WAYNE, IN 46825
FORT WAYNE, IN 46825
33aNPI1538110556assigned 05/15/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.81M
24GClaims57,189
24DCodes billed62
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#46 of 69
Median peer was paid$9.76M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,227 | $86K | |
| 2019 | 4,401 | $219K | |
| 2020 | 3,626 | $227K | |
| 2021 | 9,192 | $668K | |
| 2022 | 16,212 | $1.18M | |
| 2023 | 14,781 | $982K | |
| 2024incomplete | 5,750 | $448K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 41% | 9,244 | 7,613 | $1.58M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 39% | 8,896 | 6,807 | $1.48M |
| 71045 | Radiologic examination, chest; single view | 5.0% | 1,195 | 946 | $190K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.2% | 1,169 | 930 | $84K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 1,113 | 752 | $79K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.4% | 416 | 293 | $54K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,683 | 5,090 | $35K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,159 | 942 | $33K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 35 | 18 | $29K |
| 80053 | Comprehensive metabolic panel | <1% | 3,763 | 2,764 | $25K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,412 | 7,608 | $25K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 164 | 131 | $23K |
50 more codes
| 99217 | <1% | 53 | $22K | |
| 99218 | <1% | 64 | $22K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,128 | $17K |
| G0378 | Hospital observation service, per hour | <1% | 81 | $17K |
| 99221 | <1% | 25 | $14K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 25 | $13K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 48 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,284 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 934 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 110 | $6K |
| 87428 | <1% | 256 | $6K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 436 | $5K |
| 84484 | <1% | 570 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 155 | $3K |
| 83690 | <1% | 657 | $2K | |
| 81001 | <1% | 861 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 73 | $2K |
| 83735 | <1% | 494 | $2K | |
| 80050 | General health panel | <1% | 13 | $1K |
| 81025 | <1% | 187 | $1K | |
| 87430 | <1% | 83 | $1K | |
| 85027 | <1% | 322 | $811.20 | |
| 87641 | <1% | 60 | $703.70 | |
| 87807 | <1% | 52 | $573.08 | |
| 80076 | <1% | 154 | $464.28 | |
| 87070 | <1% | 41 | $398.46 | |
| 83605 | <1% | 38 | $249.86 | |
| 81003 | <1% | 104 | $168.75 | |
| 84703 | <1% | 31 | $156.44 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 17 | $154.35 |
| 82607 | <1% | 15 | $110.97 | |
| 76937 | <1% | 29 | $101.72 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 40 | $78.44 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 17 | $70.68 |
| 82248 | <1% | 17 | $43.88 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 375 | $0.96 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 304 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 238 | $0.00 |
| 99152 | 0% | 29 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 29 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 238 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 15 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 96 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 19 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 31 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 29 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 14 | $0.00 |
| 90744 | 0% | 14 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 14 | $0.00 |
| 88342 | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPARSONS, BRENT (CHIEF EXECUTIVE OFFICER)